Therapy

IFN Useful in HCV Patients with Cirrhosis

Published in Hepatitis Weekly, August 16th, 1999

Cirrhosis of the liver does not contraindicate interferon therapy in patients with chronic hepatitis C virus infection.

"Cirrhotic and fibrotic patients with chronic hepatitis C virus (HCV) benefit from treatment with interferon to the same degree as nonfibrotic patients if one assesses efficacy by clearance of serum HCV RNA," researcher Gregory T. Everson and colleagues wrote ("Efficacy of Interferon Treatment for Patients with Chronic Hepatitis C: Comparison of Response in Cirrhotics, Fibrotics, and Nonfibrotics," Hepatology, July 1999;30(1):271-276).

Morbidity and mortality in chronic HCV infection is primarily associated with decompensated liver...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Hepatitis Weekly

Source: Hepatitis Weekly (1999-08-16)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry